论文信息 - Sustained levodopa therapy in tardive dyskinesia.

Sustained levodopa therapy in tardive dyskinesia.

neuromuscular transnission. Neurology (NY) 1981;31:265-71. 'Lundh H. Therapeutic applications of aminopyridines in diseases of neuromuscular transmission. In: Lechat P, Thesleff S, Bowman WC, eds. Aminopyridines and Similarly Acting Drugs. Advances in the Biosciences Vol 35. Oxford: Pergamon Press, 1982:287-96. 9Molgo J, Lundh H, Thesleff S. Potency of 3,4diaminopyridine and 4-aminopyridine on mammalian neuromuscular transmission and the effect ofpH changes. Europ J Pharmacol 1980;61:25-34. '0Lechat P, Deysson G, Lemeignan M, Adolphe M. Toxicit6 aigue compose6 de quelques aminopyridines in vivo (Souris) et in vitro (cultures ceilulaires). Ann Pharmac Fr 1968;26:345-49.

A. Lees | R. Hardie | G. Stern

[1] I. Shoulson. Carbidopa/levodopa therapy of coexistent drug-induced parkinsonism and tardive dyskinesia. , 1983, Advances in neurology.

[2] C. Marsden,et al. The pathophysiology of extrapyramidal side-effects of neuroleptic drugs , 1980, Psychological Medicine.

[3] P. Seeman,et al. L-DOPA reversal of hyperdopaminergic behaviour. , 1978, Life sciences.

[4] B. Carroll,et al. Paradoxical response to dopamine agonists in tardive dyskinesia. , 1977, The American journal of psychiatry.

[5] T. Cooper. Department of Health, Education, and Welfare. , 1976, Military medicine.